We are live on ! Find out more
HIMS icon

Hims & Hers Health

197 hedge funds and large institutions have $1.12B invested in Hims & Hers Health in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 57 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $749M → $1.12B (+$373M)

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

25% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 57

22% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $11.4M

3.16% more ownership

Funds ownership: 58.74%61.9% (+3.2%)

3% more funds holding

Funds holding: 191197 (+6)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
197
Holders Change
+6
Holders Change %
+3.14%
% of All Funds
2.87%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
38
Increased
71
Reduced
57
Closed
29
Calls
$13.8M
Puts
$11.4M
Net Calls
+$2.46M
Net Calls Change
+$2.12M
Name Holding Trade Value Shares
Change
Change in
Stake
I
126
INVST
Indiana
$209K
Walleye Trading
127
Walleye Trading
New York
$207K +$92.6K +12,524 +117%
BWP
128
Baldwin Wealth Partners
Massachusetts
$197K +$23.8K +3,215 +17%
SG Americas Securities
129
SG Americas Securities
New York
$193K -$168K -22,792 -51%
VA
130
Vident Advisory
Georgia
$192K +$159K +21,545 New
BAM
131
Blueshift Asset Management
New Jersey
$180K -$45.7K -6,177 -23%
ProShare Advisors
132
ProShare Advisors
Maryland
$180K +$32.2K +4,354 +27%
OIM
133
Oder Investment Management
California
$176K +$146K +19,778 New
Victory Capital Management
134
Victory Capital Management
Texas
$163K +$25.3K +3,429 +23%
SEI Investments
135
SEI Investments
Pennsylvania
$163K +$54.9K +7,422 +68%
Los Angeles Capital Management
136
Los Angeles Capital Management
California
$158K +$1.98K +268 +2%
Citigroup
137
Citigroup
New York
$158K +$126K +17,009 +2,235%
AB
138
Amalgamated Bank
New York
$155K -$9.27K -1,254 -7%
BRWA
139
B. Riley Wealth Advisors
Florida
$155K +$129K +17,400 New
WG
140
Winton Group
United Kingdom
$151K -$12.5K -1,696 -9%
SOW
141
State of Wyoming
Wyoming
$144K +$49.6K +6,705 +70%
DM
142
Deerfield Management
New York
$137K +$114K +15,431 New
LPL Financial
143
LPL Financial
California
$135K +$13.4K +1,812 +14%
NRD
144
Nebula Research & Development
New York
$134K -$171K -23,179 -61%
CIS
145
Custom Index Systems
New York
$132K +$110K +14,858 New
Pictet Asset Management
146
Pictet Asset Management
Switzerland
$128K +$25.5K +3,445 +32%
LLWM
147
Life Line Wealth Management
California
$126K +$105K +14,197 New
Principal Financial Group
148
Principal Financial Group
Iowa
$126K +$9.12K +1,234 +10%
CIA
149
Concurrent Investment Advisors
Florida
$125K +$103K +13,997 New
State of Wisconsin Investment Board
150
State of Wisconsin Investment Board
Wisconsin
$120K -$30.7K -4,152 -24%

HIMS Hedge Fund Activity: Q4 2023 in Review

197 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q4 2023, worth a combined $1.12B — up 50% from $749M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HIMS positions and 29 closed out — a net gain of 9 holders — while 71 added to existing stakes and 57 trimmed.

The largest buyer was Bank of America, adding an estimated $19.2M. The largest seller was BIT Capital, cutting an estimated $23.1M.

  • 197 institutional investors held Hims & Hers Health (HIMS) as of Q4 2023, up from 191 in Q3 2023.
  • Funds reported $1.12B of Hims & Hers Health stock for Q4 2023, up 50% quarter-over-quarter.
  • 38 funds opened new Hims & Hers Health positions in Q4 2023 and 29 closed out, a net change of +9 holders.
  • The largest Hims & Hers Health buyer in Q4 2023 was Bank of America, an estimated $19.2M added.
  • The largest Hims & Hers Health seller in Q4 2023 was BIT Capital, an estimated $23.1M sold.

Based on aggregated 13F filings for Q4 2023.